Page 5 - Wilmot Cancer Institute | UR Medicine

The Wilmot Cancer Institute has long set the standard for excellence in cancer care in our community and beyond. We will focus on what is essential to improve future care—growing our research programs. Our talented researchers
and clinicians will focus on three key research programs: the hallmarks of cancer, immunotherapy, and cancer control and survivorship.

“To me it’s very simple. Without research, there is no treatment.

All the treatments we have today come from research.”

—Hartmut “Hucky” Land, PhD
Director of Research and Co-Director, Wilmot Cancer Institute

IMMUNOTHERAPY AND TUMOR
MICROENVIRONMENT

Immunotherapy is driving rapid progress in the treatment of many
cancers. At the Wilmot Cancer Institute, our scientists are developing
new approaches to leverage the immune system to fight cancer,
and through clinical trials, our patients have access to the latest
immunotherapies.

Wilmot is committed to investing in immunotherapy and research
that investigates the impact of the tumor microenvironment on cancer.
The tumor microenvironment consists of the normal cells, molecules,
and blood vessels that surround and feed a tumor cell. A tumor can
change its microenvironment, and the microenvironment can affect
how a tumor grows and spreads. Immunotherapy is defined as any
treatment that alters the response of the immune system, which is
often ineffective at fighting cancer, to help it attack tumors with the
sophistication and effectiveness it demonstrates when fighting other
diseases.